BioHarvest Sciences Inc. is a Canada-based biotech company. The Company is engaged in developing bio-cell growth platform technology. It operates through two segments: Superfruits and Cannabis. The Superfruits segment is engaged in the development, design, manufacture, and marketing of VINIA for the retail market. The Cannabis segment is engaged in the development, design, manufacture, and marketing of medical Cannabis. It is also involved in research and development in the cannabis industry via its Bio-Plant CELLicitation technology, which is used in the medical cannabis industry to produce cannabis cells in a process that is controlled, consistent, aseptic, non-genetically modified organisms, pesticide-free and chemical free. Its nutraceutical superfruits product, VINIA is a red grape powder to be consumed as a food that supplies the benefits of red wine consumption but without the sugar and alcohol found in wine. Its subsidiaries include BioHarvest Inc. and Dolarin Ltd.
, , , Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.